Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.
about
The risks of overlooking the diagnosis of secreting pituitary adenomasPhysiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaCushing's syndrome: epidemiology and developments in disease management.Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?Variability in laboratory parameters used for management of Cushing's syndrome.Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis.Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.Biobehavioral measures as outcomes: a cautionary tale.Managing Cushing's disease: the state of the art.Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.Cushing's syndrome: from physiological principles to diagnosis and clinical care.Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing's disease in Brazil.The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing's disease: findings from a pilot study.Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.Characterization of the serum and salivary cortisol response to the intravenous 250 µg ACTH1-24 stimulation test.Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus?Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes.
P2860
Q28076665-FE69D5CA-AC67-4D87-9EE3-A99E6B4C2D21Q34431162-046FCF7C-5230-4A16-B00C-77AE3B84BB9FQ35531889-AE6B9994-DBE0-49F5-9467-B57305CF6BCFQ36209847-0073B2BA-7B79-4A93-ABCD-CBB5BB47C039Q36327131-644874DB-F323-49DC-9A7F-BC02BCFF79BAQ36993893-948B3B83-36FB-4258-8096-50212CFC35F1Q37373227-60EC254F-E2F6-4448-A601-EDF29AF07B81Q37662797-730F9390-F70D-4C7B-8A10-2566F1398EBCQ38177740-BA83FEC3-FF42-42C4-8A2F-CA8DEF434B55Q38222170-A621CEAC-B5A5-4B7D-9C9C-FE83F3CE0043Q38284048-76D3D880-F3D3-4720-9832-0CD2E55A6337Q40632126-319818B1-B6FC-4B34-9708-ABD6A1164FB1Q41698329-5672B9B9-D1E1-4487-ABCE-DF9101C50B89Q48286861-F2A1E88A-7476-48D0-80C9-B4163CEB8C10Q48311876-39F6D96B-7659-4173-80F1-2A95AD09A1E9Q48457242-145136CA-5B1D-4051-8DE1-26ED029661DAQ51294866-5F5DBBF9-F950-4906-AB1E-545F3849773A
P2860
Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on late-night salivary ...... methodological considerations.
@en
type
label
Update on late-night salivary ...... methodological considerations.
@en
prefLabel
Update on late-night salivary ...... methodological considerations.
@en
P2860
P1433
P1476
Update on late-night salivary ...... methodological considerations.
@en
P2093
Hershel Raff
P2860
P2888
P304
P356
10.1007/S12020-013-0013-0
P577
2013-07-10T00:00:00Z